A single injection, lasting relief
Simple protocol — a single visit, effect of up to 1 year. Ideal for patients with reduced mobility.
The biocompatible cross-linking technology ensures an extended duration of action compared to plain HA.
The first viscosupplement to combine cross-linked HA and Chondroitin Sulfate for superior joint protection.
Innovative intra-articular therapy for joint health. A unique Cross-Linked combination: Hyaluronic Acid + Chondroitin Sulfate.
ORTHOFLEX one® is an innovative intra-articular viscosupplement for the treatment of osteoarthritis (arthrosis), combining in a single formula two of the most important natural components of the joint: Hyaluronic Acid and Chondroitin Sulfate, in a Cross-Linked formula with a prolonged effect.
Hyaluronic acid is the main component of the synovial fluid and of the articular cartilage.
Chondroitin is a natural component of cartilage and plays an essential role in maintaining its structure.
To maintain cartilage protection and prevent the progression of arthrosis, the treatment may be repeated periodically, on the recommendation of the specialist physician. ORTHOFLEX injections are performed exclusively by a specialist physician within authorised clinics and offices.
| Composition | Cross-linked HA 60mg + Chondroitin Sulfate 90mg |
| Volume | 3ml pre-filled syringe |
| Protocol | A single injection per treatment |
| Duration of effect | Up to 1 year |
| Molecular weight | 3.0 MilDa |
| Sterilization | Autoclaving |
| Shelf life | 2 years |
| Storage | +2°C to +25°C, original packaging |
A single injection per joint. Prior aspiration is recommended. 24h rest after the injection. Effect up to 1 year.
⚠️ Warning: Class III medical device. To be used only under the supervision of a qualified physician.
Contact us for availability, prices and partnerships. We respond within 24 hours.